Ann Chir Plast Esthet
November 2019
Objectives: The interest in the posterior aspect of the body keeps increasing, thus trigerring an increase in the number of gluteal augmentations with implants, also trigerring a proportional increase in postoperative complications and secondary gluteal surgeries. Nevertheless, there are currently few publications on this subject. The purpose of this study is to identify methods to treat and prevent gluteal augmentation complications.
View Article and Find Full Text PDFGreen infrastructure is emerging as a holistic stormwater management strategy that can also provide multi-sector benefits. Robust demonstration of project success can help leverage the appeal of green infrastructure to different sectors and open the door to a variety of funding opportunities. Yet comprehensively assessing the performance of these natural systems can be challenging, especially when communicating the benefits to a wide variety of stakeholders.
View Article and Find Full Text PDFBackground: Adult-onset growth hormone deficiency (AO-GHD) is associated with an increased prevalence of the metabolic syndrome (MetS).
Aim: To determine the effect of GH replacement on the prevalence of MetS in AO-GHD and to study the impact of MetS on the incidence of cardiovascular events during GH replacement.
Patients And Methods: 1449 AO-GHD patients (males 48.
Context: Data on the association between growth hormone (GH) replacement in patients with GH deficiency (GHD) after malignancies and new neoplasms show conflicting results.
Objective: To clarify the incidence of new malignant neoplasm in childhood-onset (CO) and adult-onset (AO) adult cancer survivors (CSs).
Design: Retrospective comparison of CO-CS and AO-CS with CO idiopathic GHD (IGHD) and AO nonfunctioning pituitary adenoma (NFPA) patients and with the general population [standardized incidence ratio (SIR)].
Context: In adults, craniopharyngioma (CP) of either childhood-onset (CO-CP) or adult-onset (AO-CP) is associated with increased morbidity and mortality, but data on the relative risks (RRs) of contributing factors are lacking.
Objective: To assess the RRs of factors contributing to morbidity and mortality in adults with CO-CP and AO-CP.
Methods: Data on 1669 patients with CP from KIMS (Pfizer International Metabolic Database) were analyzed using univariate and multiple Poisson and Cox regression methods.